pegylated IFN-alpha 2b
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pegylated IFN-alpha 2b, covering 2019-09-26 to 2019-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) [Phase 1, Phase 2]